GH Research PLC
Status: Publicly traded
Direct answer
GH Research PLC is publicly traded on NASDAQ under the ticker GHRS.
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has...
Can you invest in GH Research PLC?
Yes. GH Research PLC trades publicly on NASDAQ as GHRS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for GH Research PLC
Detailed equity research is provided by MarketSnap.